Neurometrix Inc  

(Public, NASDAQ:NURO)   Watch this stock  
Find more results for NURO
-0.03 (-1.41%)
Real-time:   1:56PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.72 - 2.15
52 week 1.58 - 10.72
Open 2.15
Vol / Avg. 787,240.00/115,389.00
Mkt cap 4.34M
P/E     -
Div/yield     -
EPS -17.01
Shares 2.35M
Beta 0.34
Inst. own 11%
Oct 19, 2017
Q3 2017 NeuroMetrix Inc Earnings Call
Sep 11, 2017
NeuroMetrix Inc at Rodman & Renshaw Global Investment Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -98.94% -123.99%
Operating margin -99.05% -126.44%
EBITD margin - -124.35%
Return on average assets -164.08% -122.32%
Return on average equity -553.63% -396.72%
Employees 44 -
CDP Score - -


1000 Winter St
WALTHAM, MA 02451-1436
United States - Map
+1-781-8909989 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Officers and directors

Shai N. Gozani M.D., Ph.D. Chairman of the Board, President, Chief Executive Officer, Secretary
Age: 50
Bio & Compensation  - Reuters
Thomas T. Higgins Chief Financial Officer, Senior Vice President, Treasurer
Age: 63
Bio & Compensation  - Reuters
Francis X. McGillin Senior Vice President, General Manager - Consumer Wearables
Age: 54
Bio & Compensation  - Reuters
David E. Goodman M.D. Independent Director
Age: 59
Bio & Compensation  - Reuters
Allen J. Hinkle M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters
Nancy E. Katz Independent Director
Age: 58
Bio & Compensation  - Reuters
Timothy R. Surgenor Independent Director
Age: 55
Bio & Compensation  - Reuters
David Van Avermaete Independent Director
Age: 63
Bio & Compensation  - Reuters